DNAプローブによる診断の世界市場

DNAプローブによる診断の世界市場は2030年までに米国で345億米ドルに達する見込み

2023年に183億米ドルと推定されるDNAプローブによる診断の世界市場は、2023年から2030年にかけてCAGR 9.5%で成長し、2030年には345億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである感染症アプリケーションは、CAGR 9.3%を記録し、分析期間終了時には204億米ドルに達すると予測されます。がんアプリケーション分野の成長率は、分析期間中CAGR 10.4%と推定されます。

米国市場は49億米ドルと推定、中国はCAGR 8.9％で成長予測

米国のDNAプローブによる診断市場は2023年に49億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに54億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.5％と7.9％と予測されています。欧州では、ドイツがCAGR約7.4%で成長すると予測されています。

世界のDNAプローブによる診断市場- 主要動向と促進要因のまとめ

DNAプローブによる診断は、病原体や遺伝子変異を特定する上で極めて重要であり、世界の感染症の増加に対処し、個別化ヘルスケアを進める上で極めて重要です。リアルタイムPCRや次世代シーケンシングなど、ゲノムシーケンスや解析の技術的進歩は、DNAプローブによる診断のスピードと精度を向上させ、市場成長を促進します。個別化医療では、個人の遺伝情報に基づいたオーダーメイドの治療戦略が求められており、特に感染症診断では、その利便性と迅速な結果が評価され、家庭用DNA診断技術が脚光を浴びています。

DNAプローブによる診断は、さまざまな薬剤に対する個人の反応に影響を与える遺伝子変異を特定する上で重要な役割を果たし、その結果、オーダーメイドの治療戦略が可能になります。ホームベースのDNA診断技術に向けた動きは、個別化された利用しやすいヘルスケアに向けた幅広い動向の一部です。磁気サンプル調製、等温増幅、LFAにとどまらず、自動サンプル調製のためのマイクロ流体工学、小型装置のための小型化PCR、DNAからの電気信号を測定する電気化学的検出法などの開発により、業界は革新を続けています。これらの技術は、家庭での診断の簡便性と有効性を高めるだけでなく、消費者による迅速な疾患のモニタリングと直接管理のための新たな道を開くと期待されています。

DNAプローブによる診断市場は、技術の進歩、ヘルスケアニーズの増大、個別化医療の重視の高まりにより、大きく成長する見込みです。これらの診断がデジタル技術と統合され、新たな医療分野に拡大するにつれて、無数の医療診断や治療のスピードと精度を向上させ、世界のヘルスケア提供の中心的存在となる可能性が高いです。デジタル技術やモバイル技術との統合は、DNAプローブによる診断のアクセシビリティを拡大し、従来のラボ環境以外での遠隔データ解析やリアルタイムモニタリングを可能にします。一つのサンプルから複数の病原体や遺伝子変化を検出できるマルチプレックス検査は、パンデミック発生や複雑な遺伝子検査の効率を高めます。自動化とハイスループットシステムは、大規模な疫学研究や臨床試験に不可欠な診断効率を高めると同時に、検査室における人的ミスの可能性を低減します。

調査対象企業の例（注目の46社）

• Abbott Molecular
• Beckman Coulter Inc.
• Becton, Dickinson and Company
• bioMerieux
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Life Sciences
• Luminex Corporation
• QIAGEN N.V.
• Siemens Healthineers
• Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

Global DNA Probes-Based Diagnostics Market to Reach US$34.5 Billion by 2030

The global market for DNA Probes-Based Diagnostics estimated at US$18.3 Billion in the year 2023, is expected to reach US$34.5 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$20.4 Billion by the end of the analysis period. Growth in the Cancer Application segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.9 Billion While China is Forecast to Grow at 8.9% CAGR

The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global DNA Probes-Based Diagnostics Market - Key Trends and Drivers Summarized

DNA probes-based diagnostics are pivotal in identifying pathogens, genetic mutations, crucial for addressing the global increase in infectious diseases and advancing personalized healthcare. Technological advancements in genomic sequencing and analysis, such as real-time PCR and next-generation sequencing, enhance the speed and accuracy of DNA probes-based diagnostics, driving market growth. Personalized medicine demands tailored therapeutic strategies based on individual genetic information, with home-based DNA diagnostic technologies gaining prominence for their convenience and rapid results, particularly in infectious disease diagnosis.

DNA probes-based diagnostics play a critical role in identifying genetic variations that affect individual responses to different medications, thus enabling tailored therapeutic strategies. The push towards home-based DNA diagnostic technologies is part of a broader trend towards personalized and accessible healthcare. Beyond magnetic sample preparation, isothermal amplification, and LFAs, the industry continues to innovate with developments in microfluidics for automated sample preparation, miniaturized PCR for compact devices, and electrochemical detection methods that measure electrical signals from DNA. These technologies not only promise to enhance the ease and effectiveness of home diagnostics but also open new avenues for rapid disease monitoring and management directly by consumers.

The market for DNA probes-based diagnostics is poised for significant growth, driven by technological advancements, increased healthcare needs, and the rising emphasis on personalized medicine. As these diagnostics become more integrated with digital technologies and expand into new medical fields, they will likely become even more central to healthcare delivery worldwide, improving the speed and accuracy of myriad medical diagnostics and treatments. Integration with digital and mobile technologies expands the accessibility of DNA probes-based diagnostics, enabling remote data analysis and real-time monitoring outside traditional lab settings. Multiplex testing, capable of detecting multiple pathogens or genetic changes from a single sample, enhances efficiency in pandemic outbreaks and complex genetic testing. Automation and high-throughput systems increase diagnostic efficiency, essential for large-scale epidemiological studies and clinical trials, while reducing human error potential in laboratories.

Select Competitors (Total 46 Featured) -

• Abbott Molecular
• Beckman Coulter Inc.
• Becton, Dickinson and Company
• bioMerieux
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Life Sciences
• Luminex Corporation
• QIAGEN N.V.
• Siemens Healthineers
• Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • DNA Probes-Based Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Genetic Disorders Strengthens Business Case for DNA Probes-Based Diagnostics
  • Growing Awareness of the Benefits of Early and Accurate Diagnosis Drives Adoption Across Various Medical Fields
  • Advances in Genomic Technologies Propel Growth of DNA Probes-Based Diagnostics Market
  • Increasing Adoption of Personalized Medicine Expands Addressable Market Opportunity for DNA Probes-Based Diagnostics
  • Growth in Infectious Disease Testing Generates Demand for Rapid DNA Probe-Based Diagnostic Solutions
  • Expansion of Point-of-Care Testing Sustains Growth in DNA Probes-Based Diagnostics Market
  • Integration of AI and Machine Learning in Diagnostics Enhances Accuracy and Efficiency
  • Focus on Genomic Research Generates Opportunities for Innovation in DNA Probes-Based Diagnostics
  • Growth in Cancer Screening Drives Use of DNA Probes-Based Diagnostic Tests
  • Adoption of DNA Probes-Based Diagnostics in Prenatal Testing Expands Addressable Market Opportunity
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World DNA Probes-Based Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Genetic Predisposition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Identity / Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• JAPAN
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Japan Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Japan 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• CHINA
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 29: China Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: China Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: China 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• EUROPE
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 33: Europe Historic Review for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 35: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• FRANCE
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: France Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: France 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• GERMANY
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 41: Germany Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Germany Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Germany 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Italy Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Italy 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 47: UK Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: UK Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: UK 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 56: Rest of World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Rest of World Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Rest of World 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION